Aarti Drugs Limited
ICICI Prudential Mutual Fund increased its stake in Aarti Drugs Limited from 2.01% to 2.04%, buying 30,370 shares. The current value of their holding is ₹70.49 crore.
A pharmaceutical manufacturer established in 1984, Aarti Drugs produces Active Pharmaceutical Ingredients, pharma intermediates, specialty chemicals, and formulations for domestic and international markets. Part of the larger Aarti Group of Industries, the company operates as a vertically integrated manufacturer serving pharmaceutical clients globally. Its diverse product portfolio spans APIs, chemical intermediates, and finished pharmaceutical formulations across multiple therapeutic segments and industrial applications.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.